| Name | Title | Contact Details |
|---|
GlySens Incorporated is a privately held corporation devoted to developing the world`s first truly long term continuous glucose monitoring system. Our goal: to enable easy, unobtrusive, worry-free diabetes control that empowers users by providing the information they need to optimize care, while freeing them to live life on their own terms.
ContextVision is a leading provider of medical image enhancement software to global equipment manufacturers. With its versatile GOP® technology at the core of its extensive product line, ContextVision enables its customers to offer clinicians unparalleled diagnostic image quality, ultimately providing patients with better care. ContextVision was established in 1983 by a specialist research team at Linköping University in Sweden. The university has been a center for digital image research and analysis. ContextVision, now considered the gold standard of medical image enhancement, offers a powerful combination of sophisticated technology and team expertise within ultrasound, x-ray, magnetic resonance imaging, mammography, interventional radiology and computed tomography. More than 150,000 systems across the globe rely on ContextVision`s market-leading products for 2D, 3D, or 4D image enhancements. Its dynamic group of image-enhancement experts customize installations for optimal image quality.
Sightpath Medical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Farnes Enterprises Corporation is a Woods Cross, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Arterys Inc. opens medical imaging to the power of the cloud. Arterys developed 4D Flow technology, which generates precise measurements of blood flow noninvasively and non-radiatively anywhere in the body.